FirstCry board clears Rs 300 crore OFS in Swara Baby via planned Rs 1,000 crore IPO
Brainbees Solutions-owned FirstCry approved a Rs 300 crore stake sale in hygiene-products contract manufacturer Swara Baby through an offer-for-sale in its planned Rs 1,000 crore IPO, pending SEBI approval. Swara Baby stays a FirstCry subsidiary post-listing. Q1 FY26 revenue rose 12% to Rs 2,163 crore though net loss stood at Rs 30.30 crore.
What happened
FirstCry's board approved selling a Rs 300 crore stake in subsidiary Swara Baby, a hygiene-products contract manufacturer, via OFS in its planned Rs 1,000 crore
Key facts
- Rs 300 crore OFS
- Rs 1,000 crore IPO target
- Rs 11,913 crore market cap
- Q1 FY26 net loss Rs 30.30 crore
- Q1 FY26 revenue Rs 2,163 crore
- revenue up 12%
Why this matters
FirstCry is unlocking value from its Swara Baby stake via a SEBI-pending IPO while keeping it a subsidiary, a template for partial monetization without ceding strategic control.
What to watch
- SEBI approval timeline and observation letters
- Q2/H1 FY26 profitability trajectory at Swara Baby
- Primary-market sentiment and comparable baby-care/FMCG IPO performance
- Anchor-investor commitments and grey-market premium signals
- Any change in FirstCry retained-stake percentage post-listing
- FirstCry files DRHP/updated prospectus for Swara Baby detailing OFS mechanics and use of proceeds
- Investor roadshows anchoring valuation of the hygiene contract-manufacturing business
- Parent Brainbees clarifies capital-allocation plan for OFS proceeds (debt paydown vs. reinvestment)
- Push to improve Swara unit economics ahead of listing to counter loss narrative